Skip to main content
Premium Trial:

Request an Annual Quote

'No Longer a Death Sentence'


A new study published in the Journal of Clinical Oncology shows that nine out of every 10 children with leukemia survive their disease, reports Bloomberg's Nicole Ostrow. Five-year survival rates for acute lymphoblastic leukemia in children rose to 90 percent in the period of 2000 to 2005, from 84 percent in 1990 to 1994, Ostrow says. "Improved drug combinations and better ways to determine treatment needs helped boost survival," she adds. "Identifying subsets of leukemia and medications, such as Novartis' Gleevec that specifically target those groups will help improve survival even more."

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.